CreatorsPublishersAdvertisers
View more in
Cancer

N-803/BCG Combo Shows Promising Responses, Tolerability in BCG-Unresponsive Bladder Cancer

onclive.com
 2021-09-10

Bacille Calmette-Guérin (BCG) plus N-803 yielded promising responses and an encouraging safety profile in patients with BCG-unresponsive, non-muscle invasive bladder cancer carcinoma in situ. Bacille Calmette-Guérin (BCG) plus N-803 (ALT-803) yielded promising responses and an encouraging safety profile in patients with BCG-unresponsive, non-muscle invasive bladder cancer (NMIBC) carcinoma in situ...

www.onclive.com

Comments / 0

Comments / 0